Literature DB >> 8539553

Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.

J Isacson1, B Trollfors, G Hedvall, J Taranger, G Zackrisson.   

Abstract

The serum IgG antibody response and decrease to 3 Bordetella pertussis antigens was compared in children with pertussis. Sera were obtained at the first clinical visit and 1, 3 and 12 months later from 89 children with > or = 3 weeks of paroxysmal cough. IgG antibodies to pertussis toxin (PT), to filamentous hemagglutinin (FHA) and to pertactin were determined with ELISA. Of 54 children with culture-confirmed pertussis or culture-confirmed familial exposure, 45 (83%) had a significant (> or = 3 fold) increase in PT IgG and 40 (74%) in FHA IgG antibodies, while only 29 (54%) had a significant increase in pertactin IgG antibodies. Significant decreases in PT, FHA and pertactin IgG antibodies were found in 34 (63%), 9 (17%) and 28 (52%) children, respectively. In the remaining 35 who did not have culture-confirmed disease, significant PT and/or FHA IgG antibody increases (criteria for pertussis according to the WHO definition) were found in 17 (49%). Only 6 of these 17 children had a significant pertactin IgG antibody increase. Of the remaining 18 children (who did not fulfil WHO criteria for pertussis), significant decreases in PT and/or FHA IgG antibodies were found in 13. We conclude that a serum IgG reaction to PT and FHA occurs in almost all children with pertussis. An increase in pertactin IgG antibodies occurs less frequently than against PT and FHA. Significant decreases in PT or FHA IgG antibodies in children with clinical pertussis might be of use as a diagnostic criterion in children brought late for examination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539553     DOI: 10.3109/00365549509019021

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 3.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

4.  Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.

Authors:  Sylvie Alonso; Eve Willery; Genevieve Renauld-Mongénie; Camille Locht
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal.

Authors:  F Simondon; I Iteman; M P Preziosi; A Yam; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

Review 6.  Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.

Authors:  Abdulbaset M Salim; Yan Liang; Paul E Kilgore
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

7.  Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection.

Authors:  Inonge van Twillert; Jacqueline A M van Gaans-van den Brink; Martien C M Poelen; Kina Helm; Betsy Kuipers; Maarten Schipper; Claire J P Boog; Theo J M Verheij; Florens G A Versteegh; Cécile A C M van Els
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.